Individualised Homeopathy After Cancer Treatment

Embed Size (px)

Citation preview

  • 8/10/2019 Individualised Homeopathy After Cancer Treatment

    1/3

    www.nursingtimes.net/ Vol 110 No 41 / Nursing Times 08.10.14 17

    Keywords:Cancer/Survivorship/

    Homeopathy

    This article has been double-blind

    peer reviewed

    Nursing PracticeResearch

    Complementary therapies

    Homeopathy can

    improve wellbeing

    Author Jennifer Poole is chartered

    psychologist and registered homeopath,

    and researcher and teacher at Nemeton

    Research Foundation, Romsey.

    AbstractPoole J (2014) Individualised

    homeopathy after cancer treatment.

    Nursing Times; 110: 41, 17-19.

    Background Increasingly, patients are

    surviving cancer and presenting with new

    health challenges, and there is greater

    demand for self-help and complementary

    and alternative medicine (CAM).

    AimTo explore the benefits of a three-

    month course of individualised

    homeopathy (IH) for survivors of cancer.

    Design Small, community-based study.

    SettingHampshire, UK.

    Method Fifteen survivors of any type of

    cancer were recruited by a walk-in cancer

    support centre. Conventional treatment

    had to have taken place within the last

    three years. Patients scored their total,

    physical and emotional wellbeing using the

    Functional Assessment of Chronic IllnessTherapy for Cancer (FACIT-G) before and

    after receiving four IH sessions.

    Results Eleven women had statistically

    positive results for emotional, physical and

    total wellbeing based on FACIT-G scores.

    ConclusionFindings support previous

    research, suggesting CAM or IH could be

    beneficial for survivors of cancer.

    Around two million people sur-

    vive cancer for more than fiveyears in the UK (Department ofHealth et al, 2010), and 50% of

    patients with cancer now live for a decadeor more (Boseley, 2014). These positive facts

    bring with them new health challenges: theUS Institute of Medicine noted that lateand long-term effects of cancer include

    5 keypoints

    1In the UK,

    around twomillion people

    currently survive

    cancer for more

    than five years

    2These patientspresent withnew health

    challenges

    3A community-basedevaluation of

    individualised

    homeopathy for

    cancer survivors

    demonstrated

    statistically

    positive results

    4Physical andemotionalwellbeing

    improved after

    three months of

    individualised

    homeopathy

    5Findingssupportprevious research,suggesting

    individualised

    homeopathy

    could benefit

    survivorship

    initiatives

    susceptibility to cardiovascular disease,diabetes, cognitive dysfunction andfatigue (Hewitt et al, 2006). Life-long post-cancer care will be required by more andmore survivors (Oeffinger and McCabe,2006), so there is a greater need for appro-priate health initiatives in symptom con-trol and management for late-stage can-cers and those that form part of the generalrecovery from cancer treatments.

    As part of Macmillan Cancer Supportsrecovery programme, patient feedback hashighlighted that survivors would like toknow how to look after themselves (Mac-millan Cancer Support, 2013). This desire isparalleled by an increased demand frompatients with long-term illness for com-plementary and alternative medicine(CAM) (Mueller, 2012). CAM functions onthe premise that the body and mind havean innate healing potential that can bestrengthened in various ways (Thompson,2009). A study of a complementary therapy

    service offering aromatherapy, massage,reflexology, shiatsu and homoeopathy topatients with cancer found benefits fromall therapies (Briscoe and Browne, 2013).The improvement rate for homeopathy

    was 21%; it is not clear whether the home-opathy was individualised to the patient.

    There are two broad methodologies inhomeopathy: Therapeutic prescribed for a specific

    ailment by name (diagnosis); Individualised aimed at combined,

    presenting psycho/physical symptoms.When accurately prescribed, the latter

    approach can evoke a positive globalimmune system response and is generallyconsidered to be holistic and patient-centred (Brien et al, 2011). Research intoindividualised homeopathy (IH) shows it

    In this article...

    Why survivors of cancer are presenting with health challenges

    Evidence supporting homeopathy use in cancer survivors Results on individualised homeopathy after cancer treatment

    A community-based evaluation of individualised homeopathy for women aftercancer treatment showed positive results for total, physical and emotional wellbeing

    Individualised homeopathyafter cancer treatment

    Alamy

  • 8/10/2019 Individualised Homeopathy After Cancer Treatment

    2/3

    18 Nursing Times 08.10.14/ Vol 110 No 41 / www.nursingtimes.net

    Nursing PracticeResearch

    There were some interesting findings. Inparticular, the two patients with stage-D(most severe) cancer (P1 and P8) had beenadvised no further medical treatment wasavailable. P8s FACIT-G scores on each scaleonly marginally improved after the IH; P1stotal FACIT-G score, however, increased by16 points (emotional = 4, physical = 12).Physical improvement did not translateinto reduced anxiety about prognosis.

    Participants in the O (no cancer) groupalso varied in outcome. For example, thetwo who had been clear of cancer long term(P7, two years; P10, three years) initiallyrated themselves highest of the group fortotal wellbeing (P7 = 69.0; P10 = 67.5). As they

    were furthest from the cancer period, thisis not surprising. Interestingly, however, P7,

    while remaining roughly the same physi-cally, increased her emotional wellbeingscore by 6.5 points after receiving IH. P10

    (who also presented with chronic herpesand a prolapsed uterus) showed the oppo-site effect, remaining the same in terms ofemotional wellbeing but increasing herphysical score by 4.5 points.

    P9 was the only participant indicating aworse physical state. She had been cancerfree for a year, but also had multiple scle-rosis, which could explain the drop in herscore. Interestingly, she recorded an overallincrease of 15.0 points in emotional well-

    being (from 7.0 to 22.0) after receiving IH,despite worsening physically. This some-

    what incongruent result may suggest otherfactors influenced her ratings.

    P11 (cancer in situ) also rated a muchgreater increase in emotional (9.5 points)compared with physical (2 points) well-

    being; she appeared to benefit greatly from

    after IH (mean = 58.1), suggesting partici-pants experienced a significant improve-ment in combined wellbeing after the IHsessions (t [10] = -5.2, P

  • 8/10/2019 Individualised Homeopathy After Cancer Treatment

    3/3

    www.nursingtimes.net/ Vol 110 No 41 / Nursing Times 08.10.14 19

    the intervention and the opportunity totalk through personal issues.

    Overall, participants showed individual

    patterns of response to IH that did not seemto be dependent on cancer stage or the timethat had passed since they received theirdiagnosis and conventional treatment.

    DiscussionThis project aimed to show IHs potential inpost-cancer-treatment care. The group as a

    whole showed statistically significant, posi-tive results for total, physical and emotional

    wellbeing, suggesting IH has a role insymptom control and general recoveryfrom conventional cancer treatment.

    Of long-term survivors of cancer,20-30% consistently report having a poorerquality of life than those who have not hadcancer. Long-term survivors also reportedpsychological problems such as anxiety(Oeffinger and McCabe, 2006). This raisescortisol levels, which, if prolonged, cansuppress immune function (Turner-Cobbet al, 2001); such cancer-based fear andanxiety could, therefore, have a directimpact on survival rates.

    In this study participants rated higherfor quality of life after receiving IH. All buttwo also improved psychologically; the psy-

    chological wellbeing of those two remainedunchanged, but both recorded improvedratings for physical and total wellbeing.

    Effect sizeEffect size combines the improvement

    with the variation found in an interventionstudy; an effect size of >0.4 is seen to indi-cate an intervention worth pursuing inpractice (Hattie, 2003). In this study IHdelivered effect sizes of 0.6 in total andphysical wellbeing, and 1.6 in emotional

    wellbeing, suggesting it can improvepatients physical and emotional wellbeing.

    Limitations and future directionsThe study had three main limitations: Absence of male participants; Small group size;

    Lack of long-term outcome measures.A larger, controlled study linked with

    an oncology outpatient unit could address

    each of these and be a positive next step.FACIT-G was an effective measure for

    this study, but is perhaps more suited topatients with cancer who have only recently

    been diagnosed and treated. In this study,the two participants whose treatment wasfurther in the past scored near to the max-imum possible before commencing IH, cre-ating a potential ceiling effect for post-IHratings; as a result, in these participants,there was a risk of the intervention beingunder-rated. Reducing time after diagnosisand treatment from three years to one (eligi-

    bility criterion) may have resolved this.

    ConclusionThis was a small, community-based studydesigned to assess the holistic potential ofIH in post-cancer-treatment care. A posi-tive effect was found, which did not appearto depend entirely on cancer diagnosis,cancer stage or time since diagnosis andconventional treatment. These resultstherefore support previous studies(Briscoe and Browne, 2013; Rostock et al,2011; Thompson and Reilly, 2002; Clover etal, 1995) that suggest CAM may benefit

    patients who have, or have had, cancer. Inaddition, a recent Swiss evaluation foundCAM interventions, especially homeop-athy, to be effective, safe and cost effective(Bornhoft and Matthiessen, 2011). Effectsizes in this study, particularly in the emo-tional wellbeing sub-scale, further supportthe suggestion that IH has a key role toplay in symptom control and generalrecovery initiatives, and could form a

    viable option within Macmillan CancerSupports recovery programme and as partof the National Cancer Survivorship Initia-tive (DH et al, 2010). NT

    The study was supported by a grant

    from the Homeopathic Action Trust (HAT).

    No part was played in the planning or

    running of the study by HAT.

    ReferencesBornhft G, Matthiessen P(2011) Homeopathy inHealthcare: An HTA Report on Homeopathy as

    Part of the Swiss Complementary Medicine

    Evaluation Programme.E-book. Berlin: Springer.Boseley S (2014) Cancer survival rates: half of NewUK patients can expect to live for another decade.

    The Guardian.19 April 2014.Brien SB et al (2011) Integrated medicine in themanagement of chronic illness: a qualitative study.

    British Journal of General Practitioners; 61: 583, 89-96.Briscoe J, Browne N(2013) Effects ofcomplementary therapies in cancer care. NursingTimes;109: 41, 18-20.Clover A et al (1995) Complementary cancertherapy: a pilot study of patients, therapies andquality of life. Complementary Therapies inMedicine;3: 3, 129-133.Department of Health et al(2010) National CancerSurvivorship Initiative: Vision.tinyurl.com/DHCancerSurvivorshipHattie J(2003) Teachers Make a Difference: What

    is the Research Evidence? tinyurl.com/TeachersDiffHewitt M et al (2006) From Cancer Patient toCancer Survivor: Lost in Transition.Washington DC:The National Academies Press.Macmillan Cancer Support(2013)After CancerTreatment: A Guide for Professionals. tinyurl.com/MacmillanAfterCancerMueller M(2012) Is homeopathy an effectivecancer treatment? The American Homoeopath;18.tinyurl.com/EffectiveHomeopathyMuellerNational Cancer Institute (2014) SEER TrainingModules. tinyurl.com/SEERCancerStageOeffinger KC, McCabe MS(2006) Models fordelivering survivorship care.Journal of ClinicalOncology;24: 32, 5117-5124.Rostock M et al(2011) Classical homeopathy in thetreatment of cancer patients a prospectiveobservational study of two independent cohorts.

    BMC Cancer;11: 19.Thompson E (2009)Adjustment andEmpowerment. Health and Homeopathy.tinyurl.com/ThompsonHomeopathyThompson E, Reilly D(2002) The homeopathicapproach to symptom control in the cancerpatient: a prospective observational study.

    Palliative Medicine;16: 3, 227-233.Turner-Cobb J et al (2001) Psychosocial effects ofimmune function and disease progression in cancer:human studies. In: Ader R et al (2001)Psycho-neuroimmunology, Vol 2.New York: Academic Press.Webster K et al (2003) The FunctionalAssessment of Chronic Illness Therapy (FACIT-G)Measurement System: properties, applications andinterpretation. Health and Quality of LifeOutcomes; 16: 1, 79.

    0

    5

    10

    15

    20

    25

    30

    1 2 3 4 5 6 7 8 9 10 11

    Before

    individualised

    homeopathy

    After

    individualised

    homeopathy

    Score

    Participant

    FIG 1. PHYSICAL WELLBEING SCORES

    For more on this topic go online...

    Effects of complementarytherapies in cancer care

    Bit.ly/NTCompTherapyCancer

    0 .00 .20 .40 .60 .81 .0

    0

    5

    10

    15

    20

    25

    1 2 3 4 5 6 7 8 9 10 11

    Before

    individualised

    homeopathy

    After

    individualised

    homeopathy

    Score

    Participant

    FIG 2. EMOTIONAL WELLBEING SCORES

    For a Nursing Times Learning unit on

    nausea and fatigue in oncology, go to

    nursingtimes.net/nausea